Last reviewed · How we verify
AJU-C52L, AJU-C52
AJU-C52L, AJU-C52 mechanism of action is not publicly available.
At a glance
| Generic name | AJU-C52L, AJU-C52 |
|---|---|
| Sponsor | AJU Pharm Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Unfortunately, there is limited information available on the mechanism of action of AJU-C52L, AJU-C52.
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of AJU-C52 in Essential Hypertension Patients (PHASE3)
- A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |